YCBD · cbdMD Inc. Common Stock
View on chartInsiders & Stakes
| Martin A. Sumichrast Chairman & CO-CEO | ▲ Buy | Grant | 1,894,533 Shares held | 5/17/2022 | View profile |
| Thomas Ronan Kennedy CFO | ▲ Buy | Grant | 513,722 Shares held | 11/28/2025 | View profile |
| Raymond Scott Coffman CO-CEO, President, Director | ▲ Buy | Grant | 387,695 Shares held | 1/11/2024 | View profile |
| Peter J. Ghiloni | ▲ Buy | Grant | 310,000 Shares held | 3/11/2022 | View profile |
| Wiesehan John J III Chief Revenue Officer | ▼ Sell | Other | 176,450 Shares held | 9/28/2021 | View profile |
| Kevin MacDermott President | ▲ Buy | Grant | 126,000 Shares held | 5/16/2022 | View profile |
| Kevin Charles Roe Director | ▲ Buy | Grant | 26,707 Shares held | 4/14/2026 | View profile |
| Clark R. Crosnoe 10% Owner | ▼ Sell | Open Market | 17,875 Shares held | 12/17/2025 | View profile |
| William F. Raines III | ▲ Buy | Grant | 13,676 Shares held | 4/14/2026 | View profile |
| Scott G. Stephen | ▲ Buy | Grant | 4,412 Shares held | 4/14/2026 | View profile |
| Bakari T. Sellers | ▲ Buy | Grant | 4,324 Shares held | 4/14/2026 | View profile |
| Sibyl Nichole Swift Director | ▲ Buy | Grant | 4,145 Shares held | 4/14/2026 | View profile |
| Jeffrey H. Porter Director | ▲ Buy | Grant | 3,144 Shares held | 4/14/2026 | View profile |
Transaction History
| Kevin Charles Roe | ▲ Buy | Grant | 1,572 | $0 | 4/14/2026 |
| Sibyl Nichole Swift | ▲ Buy | Grant | 1,572 | $0 | 4/14/2026 |
| Bakari T. Sellers | ▲ Buy | Grant | 1,572 | $0 | 4/14/2026 |
| Scott G. Stephen | ▲ Buy | Grant | 1,572 | $0 | 4/14/2026 |
| William F. Raines III | ▲ Buy | Grant | 1,572 | $0 | 4/14/2026 |
| Jeffrey H. Porter | ▲ Buy | Grant | 1,572 | $0 | 4/14/2026 |
| Clark R. Crosnoe | ▼ Sell | Open Market | 461,725 | $1.1M | 12/17/2025 |
| Clark R. Crosnoe | ▼ Sell | Open Market | 69,875 | $164K | 12/17/2025 |
| Clark R. Crosnoe | ▼ Sell | Open Market | 19,101 | $45K | 12/17/2025 |
| Thomas Ronan Kennedy | ▲ Buy | Grant | 445,000 | — | 11/28/2025 |
| Jeffrey H. Porter | ▲ Buy | Grant | 1,572 | $0 | 5/16/2025 |
| William F. Raines III | ▲ Buy | Grant | 1,572 | $0 | 5/16/2025 |
| Kevin Charles Roe | ▲ Buy | Grant | 1,572 | $0 | 5/16/2025 |
| Bakari T. Sellers | ▲ Buy | Grant | 1,572 | $0 | 5/16/2025 |
| Scott G. Stephen | ▲ Buy | Grant | 1,572 | $0 | 5/16/2025 |
| Sibyl Nichole Swift | ▲ Buy | Grant | 1,572 | $0 | 5/16/2025 |
| Jeffrey H. Porter | ▼ Sell | Other | 465,955 | — | 5/6/2025 |
| Jeffrey H. Porter | ▼ Sell | Other | 61,750 | — | 5/6/2025 |
| Jeffrey H. Porter | ▼ Sell | Other | 41,275 | — | 5/6/2025 |
| Jeffrey H. Porter | ▼ Sell | Other | 4,550 | — | 5/6/2025 |
| Thomas Ronan Kennedy | ▼ Sell | Other | 67,869 | — | 5/6/2025 |
| Kevin Charles Roe | ▼ Sell | Other | 23,563 | — | 5/6/2025 |
| William F. Raines III | ▲ Buy | Grant | 75,000 | $0 | 8/23/2024 |
| Sibyl Nichole Swift | ▲ Buy | Grant | 4,000 | $0 | 3/29/2024 |
| Scott G. Stephen | ▲ Buy | Grant | 4,000 | $0 | 3/29/2024 |
| William F. Raines III | ▲ Buy | Grant | 4,000 | $0 | 3/29/2024 |
| Bakari T. Sellers | ▲ Buy | Grant | 4,000 | $0 | 3/29/2024 |
| Raymond Scott Coffman | ▲ Buy | Grant | 13,011 | — | 1/11/2024 |
| Thomas Ronan Kennedy | ▲ Buy | Open Market | 5,000 | $11K | 5/3/2023 |
| William F. Raines III | ▲ Buy | Grant | 5,000 | $0 | 2/17/2023 |
| Bakari T. Sellers | ▲ Buy | Grant | 5,000 | $0 | 2/17/2023 |
| Scott G. Stephen | ▲ Buy | Grant | 5,000 | $0 | 2/17/2023 |
| Sibyl Nichole Swift | ▲ Buy | Grant | 5,000 | $0 | 2/17/2023 |
| Raymond Scott Coffman | ▲ Buy | Grant | 226,840 | — | 8/9/2022 |
| Sibyl Nichole Swift | ▲ Buy | Grant | 5,000 | $0 | 8/9/2022 |
| Raymond Scott Coffman | ▲ Buy | Grant | 301,253 | — | 5/17/2022 |
| Martin A. Sumichrast | ▲ Buy | Grant | 41,299 | — | 5/17/2022 |
| Kevin MacDermott | ▲ Buy | Grant | 125,000 | — | 5/16/2022 |
| Scott G. Stephen | ▲ Buy | Grant | 5,000 | $0 | 3/11/2022 |
| William F. Raines III | ▲ Buy | Grant | 5,000 | $0 | 3/11/2022 |
| Peter J. Ghiloni | ▲ Buy | Grant | 5,000 | $0 | 3/11/2022 |
| Bakari T. Sellers | ▲ Buy | Grant | 5,000 | $0 | 3/11/2022 |
| Raymond Scott Coffman | ▲ Buy | Grant | 291,646 | — | 2/28/2022 |
| Martin A. Sumichrast | ▲ Buy | Grant | 39,982 | — | 2/28/2022 |
| Martin A. Sumichrast | ▲ Buy | Option Exercise | 250,000 | — | 1/1/2022 |
| Martin A. Sumichrast | ▲ Buy | Grant | 42,004 | — | 12/28/2021 |
| Raymond Scott Coffman | ▲ Buy | Grant | 306,397 | — | 12/28/2021 |
| Thomas Ronan Kennedy | ▲ Buy | Option Exercise | 16,667 | — | 10/1/2021 |
| Thomas Ronan Kennedy | ▲ Buy | Grant | 25,000 | $0 | 10/1/2021 |
| Wiesehan John J III | ▼ Sell | Other | 161,550 | — | 9/28/2021 |
| Wiesehan John J III | ▼ Sell | Other | 150,450 | — | 9/28/2021 |
| Thomas Ronan Kennedy | ▲ Buy | Open Market | 7,400 | $15K | 8/24/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
YCBD Included in 12 Healthcare Stocks Moving in Thursday Pre‑Market
YCBD was among 12 healthcare shares that moved during Thursday’s pre‑market session, reflecting broader sector activity. The move may signal renewed interest in the company as investors react to recent market dynamics. This activity occurs while YCBD trades near its 52‑week low and an RSI of 29.1 suggests it is oversold. The pre‑market shift could influence intraday trading for the day.
YCBD Included in 12 Healthcare Stocks Moving in Thursday Pre‑Market. YCBD was among 12 healthcare shares that moved during Thursday’s pre‑market session, reflecting broader sector activity. The move may signal renewed interest in the company as investors react to recent market dynamics. This activity occurs while YCBD trades near its 52‑week low and an RSI of 29.1 suggests it is oversold. The pre‑market shift could influence intraday trading for the day.